EP0804444A1 - Novel mn(ii) carboxylate complexes, processes for their preparation and their use as disproportionation catalysts - Google Patents

Novel mn(ii) carboxylate complexes, processes for their preparation and their use as disproportionation catalysts

Info

Publication number
EP0804444A1
EP0804444A1 EP95938006A EP95938006A EP0804444A1 EP 0804444 A1 EP0804444 A1 EP 0804444A1 EP 95938006 A EP95938006 A EP 95938006A EP 95938006 A EP95938006 A EP 95938006A EP 0804444 A1 EP0804444 A1 EP 0804444A1
Authority
EP
European Patent Office
Prior art keywords
substituted
complex according
carboxylate complex
carboxylate
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95938006A
Other languages
German (de)
French (fr)
Inventor
Michael Devereux
Martin Curran
Malachy Mccann
Michael Casey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maynooth University Enterprise Development Ltd
Dublin Institute of Technology
Original Assignee
Maynooth University Enterprise Development Ltd
Dublin Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maynooth University Enterprise Development Ltd, Dublin Institute of Technology filed Critical Maynooth University Enterprise Development Ltd
Publication of EP0804444A1 publication Critical patent/EP0804444A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/39—Organic or inorganic per-compounds
    • C11D3/3902—Organic or inorganic per-compounds combined with specific additives
    • C11D3/3905—Bleach activators or bleach catalysts
    • C11D3/3932—Inorganic compounds or complexes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
    • B01J31/1815—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208—Oxygen, e.g. acetylacetonates
    • B01J31/2226—Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
    • B01J31/223—At least two oxygen atoms present in one at least bidentate or bridging ligand
    • B01J31/2234—Beta-dicarbonyl ligands, e.g. acetylacetonates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208—Oxygen, e.g. acetylacetonates
    • B01J31/2226—Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
    • B01J31/223—At least two oxygen atoms present in one at least bidentate or bridging ligand
    • B01J31/2239—Bridging ligands, e.g. OAc in Cr2(OAc)4, Pt4(OAc)8 or dicarboxylate ligands
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0213—Complexes without C-metal linkages
    • B01J2531/0216—Bi- or polynuclear complexes, i.e. comprising two or more metal coordination centres, without metal-metal bonds, e.g. Cp(Lx)Zr-imidazole-Zr(Lx)Cp
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/70—Complexes comprising metals of Group VII (VIIB) as the central metal
    • B01J2531/72—Manganese
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/04—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing carboxylic acids or their salts

Definitions

  • the present invention concerns novel manganese (II) carboxylate complexes, processes for their preparation and their use as disproportionation catalysts. More specifically, the novel complexes of the present invention are mono-, di- and poly- carboxylate complexes of manganese (II) which may, optionally, contain nitrogen and/or oxygen donor ligands. The present invention also concerns the use of the said complexes as catalysts for the disproportionation of hydrogen peroxide or the like hydrogen peroxide-liberating or generating percompounds.
  • novel complexes of the invention have advantages over other known manganese complexes that have been employed as peroxide disproportionation catalysts in that (i) they are easily synthesised from cheap, readily available starting materials and (ii) they are extremely reactive towards hydrogen peroxide.
  • Y is selected from the group comprising hydrogen, substituted or unsubstituted lower (C-*__2o) alkyl, substituted or unsubstituted lower ( 2-2O ' alkenyl, substituted or unsubstituted lower (C2-20) alkynyl, substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated carbocyclic ring system, substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon or substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated heterocyclic ring system and, when p is 2, Y additionally is selected from the group comprising substituted or unsubstituted lower (C-j__20 ⁇ alkylene, substituted or unsubstituted lower (C2-20*' alkenylene or substituted or unsubstituted lower (
  • Y is substituted by halogen, hydroxyl, lower ( -j__2o) alkoxy, nitro, a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated carbocyclic ring system, a substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon or a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated heterocyclic ring system.
  • Y is a carbocyclic ring system selected from the group comprising lower (C3_2o ⁇ cycloalkyl or a mono-, bi- or polyunsaturated derivative thereof, a fused bi- or polycyclic ring system, a bridged bi- or polycyclic ring system, optionally selected from bi- and polycyclic terpenes, and a bi- or polyspiro ring system.
  • the terpene is norbornene.
  • Y is a substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon, preferably Cg_*j_2 aryl, optionally selected from phenyl, benzyl, naphthalenyl and anthracenyl, Y being optionally ' substituted by halogen, hydroxyl, lower (C]__2 ⁇ ) alkoxy or nitro.
  • Y is naphthalenyl or 2-hydroxy-l- phenyl or, alternatively, Y is (C]__-*_o) lower alkylene, optionally selected from dimethylene, trimethylene, tetramethylene, pentamethylene and hexamethylene; p is 2; and m and q are each 0.
  • Y is lower (C2- 10 ) alkenyl substituted by halogen, hydroxyl, lower (C-*__2o) alkoxy, nitro, a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated carbocyclic ring system, a substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon or a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated heterocyclic ring system. More preferably Y is a lower (C 2 -1 0 ) alkenyl, optionally acrylyl, substituted by a heterocyclic ring system, most preferably imidazol-4-yl.
  • the Mn(II) carboxylate complex additionally comprises at least one nitrogen donor ligand selected from substituted or unsubstituted saturated or unsaturated ring nitrogen-containing mono-, bi-, or polycyclic ring systems, ammonia, substituted or unsubstituted primary, secondary and tertiary amines or bi- or polycyclic fused ring systems .
  • nitrogen donor ligand selected from substituted or unsubstituted saturated or unsaturated ring nitrogen-containing mono-, bi-, or polycyclic ring systems, ammonia, substituted or unsubstituted primary, secondary and tertiary amines or bi- or polycyclic fused ring systems .
  • the nitrogen donor ligand is selected from substituted or unsubstituted pyridine, 1, 10-phenanthroline and 2, 2 ' -bipyridine.
  • the Mn(II) carboxylate complex additionally comprises at least one oxygen donor ligand optionally selected from water, hydronium ions and lower (C-j__2 ⁇ ) alkanols, preferably ethanol .
  • a process for the preparation of a Mn(II) carboxylate complex as defined hereinabove which process comprises reacting a Mn(II) salt of the formula
  • L is a leaving group which may optionally be selected from acetate and halogen, preferably chloride, with an appropriate carboxylic acid, or a salt thereof, in a suitable reaction medium, preferably selected from water or an ethanol :water mixture, more preferably a 4:1 (v:v) ethanol :water mixture, to obtain the Mn(II) carboxylate complex.
  • a suitable reaction medium preferably selected from water or an ethanol :water mixture, more preferably a 4:1 (v:v) ethanol :water mixture
  • a catalyst for accelerating the disproportionation of hydrogen peroxide, hydrogen peroxide-liberating percompounds and hydrogen peroxide-generating percompounds comprising a Mn(II) carboxylate complex as defined hereinabove.
  • carboxylate when used in the expressions "Mn(II) carboxylate complex” and "Mn(II) -carboxylate-nitrogen donor complex” and the like expressions is intended to embrace mono-, bi- and poly-carboxylate complexes.
  • hydroxogen peroxide percompound is intended to embrace alkali metal peroxides, as well as alkali metal perborates, percarbonates, perphosphates and persulphates.
  • a simple manganese (II) salt eg. manganese (II) acetate tetrahydrate or manganese (II) chloride tetrahydrate
  • an excess of the appropriate carboxylic acid or the sodium salt of the acid
  • water or an ethanol.-water mixture (4:1) (v:v) to give a suspension (or a solution) of the respective manganese (II) carboxylate complex in high yield.
  • This manganese (II) carboxylate complex may then be added to a solution of a selected nitrogen donor base (N-base) to give the respective manganese (II) carboxylate/N-base complex in good yield.
  • a simple manganese (II) salt eg. manganese (II) acetate tetrahydrate or manganese (II) chloride tetrahydrate
  • an excess of the appropriate carboxylic acid or the sodium salt of the acid
  • water or an ethanol :water mixture (4:1) (v:v) containing the dissolved nitrogen donor base (N-base) e.g., water or an ethanol :water mixture (4:1) (v:v) containing the dissolved nitrogen donor base (N-base) .
  • the respective manganese (II) carboxylate/N-base complex is isolated in good yield.
  • odaH2 octanedioic acid
  • salH2 salicylic acid
  • ndaH2 cis-5-norbornene-endo-2, 3-dicarboxylic acid
  • bdoaH2 benzene-1, 2-dioxyacetic acid
  • bndaH2 1, 1 ' -binaphtho-2, 2 ' -diacetic acid
  • bdaH2 butanedioic acid
  • phen 1, 10-phenanthroline
  • py pyridine
  • bipy 2, 2 ' -bipyridine
  • E-uro E-urocanic acid (E-4-imidazole acrylic acid) .
  • Example 1 Mn(oda) .H2 ⁇ (Complex 1) Mn(CH 3 C0 2 ) 2* 4 H2 ⁇ (1-0 g, 4.08 mmol) and octanedioic acid (0.825 g, 4.74 mmol) were refluxed together in an ethanol:water mixture (4:1) (100 ml) for 2 h. The white product (1) was filtered off, washed with ethanol and then air-dried. Yield 76%. Calc: C, 39.19; H, 5.76.
  • IR (Csl matrix) 3580, 3520, 3060, 1600, 1490, 1440, 1390, 1350, 1240, 1150, 1030, 1020, 850, 760, 705, 660, 570, 540, 470, 390 cm" 1 .
  • Complex (5) was readily soluble in aqueous ethanol, hot water and hot ethanol.
  • IR Csl matrix
  • Complex (8) readily dissolves in water and in warm ethanol .
  • Example 12 [Mn(bnda) (phen)2 (H2O)2] (Complex 12) To a suspension of complex (11) (0.5 g, 0.98 mmol) in an ethanol :water mixture (4:1) (100 ml) was added 1, 10-phenanthroline (1.2 g, 6.67 mmol) . The resulting mixture was then refluxed for 2 hours. Upon cooling the light-green solution was filtered and, on standing for several days, green crystals of the product formed. The solid was filtered off, washed with ice-cold ethanol and then air-dried at ca 20°C. Calc: C, 67.79; H, 4.23; N. 6.58.
  • This complex comprises a dimanganese (II, II) dianion and a dimanganese (II, II) dication.
  • dianion [Mn2 (oda) 3 (phen) 4] 2"
  • An oda 2- ligand bridges the two metals by using one carboxylate oxygen from each end of the dicarboxylate ligand.
  • a monodentate oda 2- ligand is coordinated to each metal via a single carboxylate oxygen, and this is in a cis position with respect to the bridging carboxylate oxygen. The three remaining oxygen atoms of this oda 2" ligand remain uncoordinated.
  • each Mn(II) atom is at the centre of a distorted N 4 O2 octahedron.
  • the structure of the dication [Mn2 (oda) (phen) 4 (H2O) 2] 2+ is basically similar to that of the dianion in that each of the two symmetry related Mn(II) atoms has a distorted octahedral 4 O2 coordination geometry.
  • Each metal is surrounded by two chelating phen groups and one carboxylate oxygen atom from the bridging oda 2 " ligand.
  • the sixth coordination site is occupied by the oxygen atom of a water molecule which, again, is in a cisoid position with respect to the coordinated carboxylate oxygen atom of the bridging oda 2 " ligand.
  • the complex comprises two associated and symmetry related pseudo seven-coordinate Mn(II) centres.
  • Each Mn is asymmetrically chelated by two salH " (HOC/5H 4 CO2 " ) ligands and, perpendicular to the central plane, there are two coordinated water molecules. Association of the two metals occurs via the carboxylate oxygen atoms from a second pair of chelating salH ⁇ ligands, effectively creating two asymmetric bridges between the Mn atoms.
  • the stability of complex (3) in the solid state is further enhanced by intramolecular hydrogen bonding between the hydroxyl groups of the salH" function and one carboxylate oxygen of the same ligand. [ ⁇ Mn 2 ( sal ) 2 ( salH) ( H 2 0 ) (H 3 0) (py) 4 - 2py ⁇ n ] (Complex 4 )
  • the complex comprises three independent Mn(II) atoms ⁇ Mnl, Mn2 and Mn3 ⁇ in a polymeric system of the type
  • Mn2 lies on another inversion centre and it has an N 2 O 4 octahedral coordination geometry identical to that of Mnl.
  • Mn3 is in a general position, and is bonded to the second carboxylate oxygen atom from the sal 2 " ligand which is coordinated to Mnl, and also to the second carboxylate oxygen atom from the sal 2 " ligand which is coordinated to Mn2.
  • the coordination mode of the carboxylate moieties of both of these bridging sal 2 " ligands is syn-anti bidentate.
  • the oxygen atom of a water molecule and the oxygen atom of a cisoid hydronium ion (H 3 0 + : oxygen donor ligand) are also coordinated to Mn3, and the N2O octahedral coordination about the metal is completed by two axial pyridine ligands.
  • a salH" ion is hydrogen bonded via its carboxylate oxygens in a syn-syn bidentate bridging mode to the water molecule and to the hydronium ion which are coordinated to Mn3. Additional inter-ligand hydrogen bonding interactions are also present.
  • the salicylate carboxylate groups each form asymmetric bridges to further manganese atoms, forming spiral chains parallel to the two-fold screw axis.
  • the complex comprises a single manganese (II) atom in a distorted six-coordinate geometry.
  • the metal is ligated by two chelating phenanthroline ligands and two carboxylate oxygen atoms (one from each of the two carboxylate functions on the nda 2" ligand) .
  • the water molecule is hydrogen bonded to one of the free carbonyl oxygens of the nda 2 " ligand.
  • the ethanol molecule is hydrogen bonded to this water molecule.
  • the complex comprises a single seven-coordinate manganese (II) ion.
  • the bdoa 2" acts as a chelating quadridentate ligand and is bound to the metal via the two ethereal oxygen atoms and two carboxylate oxygens, one from each end of the diacid. The remaining three coordination sites are occupied by the oxygen atoms of three water molecules. [Mn ( E-uro ) 2 (H 2 0) 4 ] ( Complex 14 )
  • This complex shows two distinct isomers of [Mn(E-uro) 2 (H2O) 4] .
  • One isomer has the imine nitrogen atom of the imidazole ring lying in a cisoid orientation with respect to the carbon-carbon double bond which bears the pendant carboxylate group, whilst in the other isomer the same nitrogen atom is transoid to the double bond.
  • Both species are centrosymmetric, so that the asymmetric unit comprises two independent half molecules.
  • the geometry at manganese is approximately octahedral, with the metal coordinated by the imine nitrogen atoms from two urocanate anions trans to one another, and also by four water molecules.
  • the reaction flask was equipped with a magnetic stirring bar and thermostatted at 25°C.
  • Solid complex (ca 10 mg) and solid imidazole (50 mg) were added to the flask, and then aqueous H2O2 (35% w/w, 10 ml, 114 mmol) was injected using a syringe.
  • the resulting mixture was stirred, and the evolved O2 was measured volumetrically (ml) over a period of time (min) .
  • the results are set out in Table 1 hereinbelow.
  • Example 17 H2O2 Disproportionation Results for Complexes (2) and (8) .
  • the reaction flask was equipped with a magnetic stirring bar and thermostatted at 25°C. Solid complex (ca 10 mg) was added to the flask, and then aqueous H2O2 (35% w/w, 5 ml, 57 mmol) was injected using a syringe. The resulting mixture was stirred, and the evolved O2 was measured volumetrically (ml) over a period of time (min) (see Table 2 annexed) .
  • the complexes of the invention also catalyze the disproportionation of H2O2 in the absence of imidazole.
  • Mn (II) carboxylate complexes of the present invention have been tested in contact with various stains such as tea, coffee and red wine. It is been shown, in these tests, that the complexes of the invention act as effective bleaching catalysts, either in the presence of a nitrogen donor ligand such as imidazole or 1, 10-phenanthroline or in the absence of a nitrogen donor ligand. Accordingly, Mn (II) carboxylate complexes of the present invention are suitable for use in surface cleaners and washing powders .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)

Abstract

The present invention concerns novel maganese (II) carboxylate complexes having utility as disproportionation catalysts and processes for their preparation. The invention provides Mn(II) carboxylate complexes or their binuclear or polynuclear derivatives, in which the carboxylate moiety is of the general formula: Y[Om(CH2)qCOOH]p in which m is 0 or 1; q is » 0; p is » 1; and Y, which may be substituted or unsubstituted, is selected from lower alkyl, lower alkenyl, lower alkynyl, a carbocyclic ring system, an aromatic hydrocarbon or a heterocyclic ring system and, when p is 2, Y, which may also be substituted or unsubstituted, is additionally selected from lower alkylene, lower alkenylene or lower alkynylene, with the proviso that, when m is 0 and q is 0 or 1 and p is 1, Y is not hydrogen.

Description

NOVEL MN(II) CARBOXYLATE COMPLEXES, PROCESSES
FOR THEIR PREPARATION AND THEIR USE AS
DISPROPORTIONATION CATALYSTS
Introduction
The present invention concerns novel manganese (II) carboxylate complexes, processes for their preparation and their use as disproportionation catalysts. More specifically, the novel complexes of the present invention are mono-, di- and poly- carboxylate complexes of manganese (II) which may, optionally, contain nitrogen and/or oxygen donor ligands. The present invention also concerns the use of the said complexes as catalysts for the disproportionation of hydrogen peroxide or the like hydrogen peroxide-liberating or generating percompounds. The novel complexes of the invention have advantages over other known manganese complexes that have been employed as peroxide disproportionation catalysts in that (i) they are easily synthesised from cheap, readily available starting materials and (ii) they are extremely reactive towards hydrogen peroxide.
According to a first aspect of the invention there is provided a Mn(II) carboxylate complex or a binuclear or polynuclear derivative thereof, in which the carboxylate moiety is of the general formula Y[Orn(CH2)qCOOH]p
in which m is 0 or 1; q is ≥ 0; p is ≥ 1; and Y is selected from the group comprising hydrogen, substituted or unsubstituted lower (C-*__2o) alkyl, substituted or unsubstituted lower ( 2-2O' alkenyl, substituted or unsubstituted lower (C2-20) alkynyl, substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated carbocyclic ring system, substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon or substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated heterocyclic ring system and, when p is 2, Y additionally is selected from the group comprising substituted or unsubstituted lower (C-j__20< alkylene, substituted or unsubstituted lower (C2-20*' alkenylene or substituted or unsubstituted lower (C2-20) alkynylene; with the proviso that, when m is 0 and q is 0 or 1 and p is 1, Y is not hydrogen.
Preferably Y is substituted by halogen, hydroxyl, lower ( -j__2o) alkoxy, nitro, a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated carbocyclic ring system, a substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon or a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated heterocyclic ring system.
More preferably Y is a carbocyclic ring system selected from the group comprising lower (C3_2o< cycloalkyl or a mono-, bi- or polyunsaturated derivative thereof, a fused bi- or polycyclic ring system, a bridged bi- or polycyclic ring system, optionally selected from bi- and polycyclic terpenes, and a bi- or polyspiro ring system. Advantageously, the terpene is norbornene.
Advantageously Y is a substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon, preferably Cg_*j_2 aryl, optionally selected from phenyl, benzyl, naphthalenyl and anthracenyl, Y being optionally' substituted by halogen, hydroxyl, lower (C]__2θ) alkoxy or nitro.
More advantageously, Y is naphthalenyl or 2-hydroxy-l- phenyl or, alternatively, Y is (C]__-*_o) lower alkylene, optionally selected from dimethylene, trimethylene, tetramethylene, pentamethylene and hexamethylene; p is 2; and m and q are each 0.
Preferably Y is lower (C2-10) alkenyl substituted by halogen, hydroxyl, lower (C-*__2o) alkoxy, nitro, a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated carbocyclic ring system, a substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon or a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated heterocyclic ring system. More preferably Y is a lower (C2-10) alkenyl, optionally acrylyl, substituted by a heterocyclic ring system, most preferably imidazol-4-yl. Preferably, the Mn(II) carboxylate complex additionally comprises at least one nitrogen donor ligand selected from substituted or unsubstituted saturated or unsaturated ring nitrogen-containing mono-, bi-, or polycyclic ring systems, ammonia, substituted or unsubstituted primary, secondary and tertiary amines or bi- or polycyclic fused ring systems .
More preferably, the nitrogen donor ligand is selected from substituted or unsubstituted pyridine, 1, 10-phenanthroline and 2, 2 ' -bipyridine.
Advantageously, the Mn(II) carboxylate complex additionally comprises at least one oxygen donor ligand optionally selected from water, hydronium ions and lower (C-j__2θ) alkanols, preferably ethanol .
According to a second aspect of the invention there is provided a process for the preparation of a Mn(II) carboxylate complex as defined hereinabove, which process comprises reacting a Mn(II) salt of the formula
Mn (II) L
in which L is a leaving group which may optionally be selected from acetate and halogen, preferably chloride, with an appropriate carboxylic acid, or a salt thereof, in a suitable reaction medium, preferably selected from water or an ethanol :water mixture, more preferably a 4:1 (v:v) ethanol :water mixture, to obtain the Mn(II) carboxylate complex. The invention also provides a process for the preparation of a Mn(II) -carboxylate-nitrogen donor ligand complex as defined hereinabove, which process comprises:
(i) (a) reacting a Mn(II) salt of the formula
Mn(II)L in which L is a leaving group which may optionally be selected from acetate and halogen, preferably chloride, with an appropriate carboxylic acid, or a salt thereof, in a suitable reaction medium, preferably selected from water or an ethanol:water mixture, more preferably a 4:1 (v:v) ethanol:water mixture, to obtain a Mn(II) carboxylate complex; and (i) (b) reacting the Mn(II) carboxylate complex with an appropriate nitrogen donor ligand to obtain the Mn(II) -carboxylate-nitrogen donor ligand complex of the invention; or
(ii) reacting a Mn(II) salt of the formula Mn(II)L in which L is a leaving group which may optionally be selected from acetate and halogen, preferably chloride, with an appropriate carboxylic acid, or a salt thereof, in a suitable reaction medium, preferably selected from water or an ethanol:water mixture, more preferably a 4:1 (v:v) ethanol:water mixture, the reaction medium also containing an appropriate nitrogen donor ligand, to obtain the Mn(II) -carboxylate-nitrogen donor ligand complex of the invention.
According to a third aspect of the invention there is provided use of Mn(II) carboxylate complexes as defined hereinabove as disproportionation catalysts.
According to a fourth aspect of the invention there is provided a catalyst for accelerating the disproportionation of hydrogen peroxide, hydrogen peroxide-liberating percompounds and hydrogen peroxide-generating percompounds, the catalyst comprising a Mn(II) carboxylate complex as defined hereinabove.
The term "carboxylate" when used in the expressions "Mn(II) carboxylate complex" and "Mn(II) -carboxylate-nitrogen donor complex" and the like expressions is intended to embrace mono-, bi- and poly-carboxylate complexes.
The term "hydrogen peroxide percompound" is intended to embrace alkali metal peroxides, as well as alkali metal perborates, percarbonates, perphosphates and persulphates.
General Preparation of the Manganese(II) Carboxylate Complexes of the Invention
Method (a) : The Two-Stage Synthetic Route:
A simple manganese (II) salt (eg. manganese (II) acetate tetrahydrate or manganese (II) chloride tetrahydrate) is reacted with an excess of the appropriate carboxylic acid (or the sodium salt of the acid) in water or an ethanol.-water mixture (4:1) (v:v) to give a suspension (or a solution) of the respective manganese (II) carboxylate complex in high yield. This manganese (II) carboxylate complex may then be added to a solution of a selected nitrogen donor base (N-base) to give the respective manganese (II) carboxylate/N-base complex in good yield.
Method (b) : The Single-stage Synthetic Route:
A simple manganese (II) salt (eg. manganese (II) acetate tetrahydrate or manganese (II) chloride tetrahydrate) is reacted with an excess of the appropriate carboxylic acid (or the sodium salt of the acid) in water or an ethanol :water mixture (4:1) (v:v) containing the dissolved nitrogen donor base (N-base) . The respective manganese (II) carboxylate/N-base complex is isolated in good yield.
ABBREVIATIONS
odaH2= octanedioic acid; salH2 = salicylic acid; ndaH2 = cis-5-norbornene-endo-2, 3-dicarboxylic acid; bdoaH2 = benzene-1, 2-dioxyacetic acid; bndaH2= 1, 1 ' -binaphtho-2, 2 ' -diacetic acid; bdaH2= butanedioic acid; phen = 1, 10-phenanthroline; py = pyridine; bipy = 2, 2 ' -bipyridine; E-uro = E-urocanic acid (E-4-imidazole acrylic acid) .
Detailed Preparation of the Manganese(II) Carboxylate Complexes of the Invention
Example 1: Mn(oda) .H2θ (Complex 1) Mn(CH3C02 )2*4H2θ (1-0 g, 4.08 mmol) and octanedioic acid (0.825 g, 4.74 mmol) were refluxed together in an ethanol:water mixture (4:1) (100 ml) for 2 h. The white product (1) was filtered off, washed with ethanol and then air-dried. Yield 76%. Calc: C, 39.19; H, 5.76. Found: C, 39.64; H, 5.63%; IR (Csl matrix) : 3550, 2940, 1560, 1420, 1355, 1190, 1000, 810, 710, 425 cm-1. Complex (1) was insoluble in all common solvents.
Example 2: [Mn2 (oda) (phen)4 (H2O ) 2] [Mn2 (oda) 3 (phen) 4] .4H2O (Complex 2)
Complex (1) (0.5 g, 2.04 mmol) and 1, 10-phenanthroline (1.13 g, 6.27 mmol) were refluxed together in an ethanol :water mixture (4:1) (50 ml) for 45 min. The resulting yellow solution was allowed to cool to room temperature and on standing the product (2) formed as yellow crystals. The crystals were filtered off, washed with ice-cold ethanol and then air-dried. Yield 51%. More of complex (2) was obtained upon concentration of the reaction filtrate. Overall yield of (2) was 80%. Calc: C, 62.54; H, 5.08; N, 9.12. Found: C, 61.34; H, 5.03; N, 8.69%; IR (Csl matrix) : 3400, 2940, 1570, 1520, 1425, 870, 850, 730 cm"1; Uv/vis: Xmax (H20^ 345 nm (sh) . Complex (2) readily dissolves in warm water and in warm ethanol.
Example 3: [Mn2 (salH)4 (H2O)4] (Complex 3)
To a solution of NaOH (0.436 g, 10.9 mmol) in water (150 ml) was added salicylic acid (1.513 g, 10.9 mmol) and MnCl2.4i-.2O (1.039 g, 5.3 mmol). The resulting solution was refluxed for 3 hours and then concentrated to ca. 50 ml. On standing for a few days at room temperature, complex (3) formed as colourless crystals in essentially quantitative yield. IR (KBr matrix) : 3700, 1630, 1540, 1480, 1410 cm"1. Complex (3) was soluble in water, ethanol, methanol, dimethylfuran and tetrahydrofuran and insoluble in diethyl ether.
Example 4: [{Mn2 (sal)2 (salH) (H20) (H30) (py)4.2py}n] (Complex 4)
A dark-green solution of complex (3) (1.0 g, 1.37 mmol) in pyridine (25 ml) was refluxed for 0.5 h. After cooling to room temperature, the solution was concentrated in vacuo to give dark green crystals of complex (4) . The solid was filtered off, washed with diethyl ether and then air-dried. Yield 60%. IR (KBr matrix) : 3700, 1620, 1560, 1535, 1440 cm"1; UV-vis (in EtOH) :Xmax= 561 nm, Σ = 276 dm3 mol'^-cm"1. Complex (4) was soluble in ethanol, acetone, pyridine and dimethyl sulphoxide and insoluble in diethyl ether.
Example 5: [{Mn(salH) (bipy) (H20) }n] (Complex 5)
To a solution of complex (3) (0.4 g, 0.55 mmol) in an ethanol:water mixtπre (4:1) (50 ml) was added 2,2'- bipyridine (0.2 g, 1.2d mmol), and the resulting mixture was refluxed for 1 :r. On standing for a number of days, the pale green solution yielded yellow crystals of (5) . The solid was filtered off, washed with a small portion of ethanol and then air-dried at ca 20°C. Yield (15%) . Calc: C, 57.3; H, 4.0; N, 5.6% Found: C, 57.5; H, 4.0; N, 5.71%. IR (Csl matrix) : 3580, 3520, 3060, 1600, 1490, 1440, 1390, 1350, 1240, 1150, 1030, 1020, 850, 760, 705, 660, 570, 540, 470, 390 cm"1. Complex (5) was readily soluble in aqueous ethanol, hot water and hot ethanol.
Example 6: [Mn(salH)2 (phen) ] (Complex 6)
To a solution of complex (3) (0.4 g, 0.548 mmol) in an ethanol :water mixture (4:1) (50 ml) was added 1, 10-phenanthroline (0.23 g, 1.276 mmol) . The mixture was stirred at room temperature for 2 hours and, upon standing, the green product precipitated. The solid was filtered off, washed with a small portion of ethanol and then air-dried at ca 20°C. Yield 55%. Calc: C, 61.30; H, 3.54; N, 5.50. Found: C, 61.20; H, 3.69; N. 5.77%. IR(CsI matrix) : 3420, 3070, 1660, 1600, 1490, 1470, 1395, 1350, 1260, 870, 765 cm"1. Complex (6) readily dissolves in hot ethanol and in hot water.
Example 7: [Mn(nda) (H2O)] (Complex 7)
To a solution of ndaJ-^d.O g, 5.49 mmol) and NaOH (0.48 g, 12.0 mmol) in distilled water (100 ml) was added MnCl2.4H 0 (0.98 g, 4.96 mmol) . The resulting colourless solution was stirred at room temperature for 3 hours. The solution was concentrated by slow evaporation to yield the product as light pink crystals. The solid was filtered off, washed with a small volume of cold water and then air-dried at ca 25°C. Yield 0.94 g (75%) . Calc: C, 42.7; H, 3.99. Found: C, 42.5; H, 3.94%. IR (Csl matrix) : 3410, 3000, 1650, 1550, 1480, 1430, 1350, 1315, 1250, 800, 655 cm"1. Complex (7) was insoluble in all common solvents.
Example 8: (Complex 8)
To a suspension of complex (7) (0.37 g, 1.46 mmol) in an ethanol :water mixture (4:1) (100 ml) was added
1, 10-phenanthroline (1.5 g) . The resulting mixture was refluxed for 0.75 hours to give a yellow solution. Upon standing for several days, yellow crystals of the product (8) were deposited. The solid was filtered off, washed with a small portion of ice-cold ethanol and air-dried at ca 25°C. Yield 0.25g (65.4%) . Calc : C, 63.73; H, 4.90; N, 8.50. Found: C, 64.56; H, 4.66; N, 8.40%. IR (Csl matrix) : 3800, 3000, 1610, 1590, 1545, 1520, 1430, 1400, 1375, 1350, 1305, 1290, 1100, 860, 750, 735, 640 cm"1. Complex (8) readily dissolves in water and in warm ethanol .
Example 9: [Mn(bdoa) (H2O) 3] (Complex 9)
To a solution of bdoaH2(2.55 g, 11.3 mmol) in an ethanol rwater mixture (4:1) (100 ml) was added Mn(CH3Cθ2) 2 *4H2° (2-55 g, 10.4 mmol) . The mixture was refluxed for 2 hours. Upon cooling a colourless solid precipitated. This crude material was filtered and recrystallised from hot water to give colourless crystals of (9) . The solid was filtered off, washed with a small portion of ice-cold ethanol and air-dried at ca 25°C. Yield 89.4%. Calc: C, 36.05, H, 4.24. Found: C, 39.67; H, 3.16%. IR (Csl matrix) : 3400, 1600, 1505, 1420, 755 cm"1. Complex (9) was soluble in hot water and in ethanol.
Example 10: [Mn(bdoa) (phen) 2 (H2O) ] (Complex 10)
To a solution of complex (9) (0.4 g, 1.2 mmol) in an ethanol :water mixture (4:1) (50ml) was added 1, 10-phenanthroline (0.65 g, 3.6 mmol) . The mixture was refluxed for 2 hours and upon cooling the yellow product (10) precipitated. The solid was filtered off, washed with cool ethanol, and air-dried at ca 20°C. Yield 70%. Calc: C, 62.10; H, 4.00; N. 8.52. Found: C, 62.00; H, 4.30; N. 8.13%. IR (Csl matrix) 3400, 3050, 2960, 1635, 1500, 1420, 840, 720 cm"1. Complex (10) was soluble in water and in methanol .
Example 11: [Mn(bnda) (H20)3] (Complex 11)
To a solution of Mn(CH3C02) 2 •4H20 (0.25 g, 1.02 mmol) in an ethanol :water mixture (4:1) (50 ml) was added bndaH2(0.45 g, 1.12 mmol) . The mixture was refluxed for 2 hours and allowed to cool. The solid was filtered off, washed with ethanol and air-dried at ca 20°C. Yield 78%. Calc: C, 56.58; H, 4.37. Found: C, 56.48; H, 3.44%. IR (Csl matrix) : 3380, 3040, 1590, 1420, 1215 cm"1. Complex (11) was insoluble in water and in ethanol .
Example 12: [Mn(bnda) (phen)2 (H2O)2] (Complex 12) To a suspension of complex (11) (0.5 g, 0.98 mmol) in an ethanol :water mixture (4:1) (100 ml) was added 1, 10-phenanthroline (1.2 g, 6.67 mmol) . The resulting mixture was then refluxed for 2 hours. Upon cooling the light-green solution was filtered and, on standing for several days, green crystals of the product formed. The solid was filtered off, washed with ice-cold ethanol and then air-dried at ca 20°C. Calc: C, 67.79; H, 4.23; N. 6.58. Found: C, 67.79; H, 3.70; N, 6.62%. IR (Csl matrix) : 3400, 3040, 1615, 1420, 1270, 845 cm-1. Complex (12) was only sparingly soluble in hot ethanol and was insoluble in water.
Example 13: [Mn(bda) (H2O) 2] (Complex 13)
To a solution of Mn(CH3C02 ) 2 *4 2° (°*4 9- 1 - 6- mmol) in an ethanol : ater mixture (4:1) (50 ml) was added bdaH2 (0.23g, 1.95 mmol) . The mixture was refluxed for 2 hours and on cooling a colourless precipitate formed. The solid was filtered, washed with ethanol and was air-dried at ca 20°C. Yield 68%. Calc: C, 23.2; H, 3.9. Found: C, 22.2; H. 3.2%. IR (Csl matrix) : 3200, 1570, 1380, 1220, 650 cm"1. Complex (13) was readily soluble in water.
Example 14: [Mn(E-uro) 2 (H2O)4] (Complex 14)
NaOH(0.2 g, 5.0 mmol) was dissolved in water (100 ml) and E-urocanic acid (0.9 g, 6.5 mmol) was added. The mixture was stirred for 3 h and then filtered. To the colourless filtrate was added MnCl2-4H2θ (0.43 g, 2.17 mmol) , and the mixture was then stirred for 2 h. The resulting white solid product was filtered off, washed twice with water and then left to air-dry at ca 25°C. Yield 0.7 g (80%) . Found: C, 36.2; H, 4.6; N, 13.8%. Calc: C, 35.9; H, 4.5; N, 13.9%; μ = 5.94 B.M.; IR (Csl matrix) : 3350, 3095, 2860, 1660, 1530, 1480, 1380, 1345, 1260, 1170, 1120, 1000, 970, 955, 880, 850, 790, 685, 660, 400 cm"1. Complex (14) was soluble in warm water and insoluble in alcohols .
NOTE: All of the complexes (1)-(14) had magnetic moments in the range expected for simple manganese (II) species, i.e., those lacking Mn-Mn interactions.
Example 15: X-RAY CRYSTALLOGRAPHIC STUDIES
The structures of complexes (2) , (3) , (4) , (5) , (8) , (9) and (14) have been determined using X-ray crystallography, and these are described below.
[Mn2 (oda) (phen) 4 (H20)2] [Mn2 (oda)3 (phen)4] .4H20 (Complex 2)
This complex comprises a dimanganese (II, II) dianion and a dimanganese (II, II) dication. In the dianion [Mn2 (oda) 3 (phen) 4] 2" , each of the two symmetry related Mn(II) atoms are ligated by the nitrogen atoms of two chelating phen groups. An oda2- ligand bridges the two metals by using one carboxylate oxygen from each end of the dicarboxylate ligand. A monodentate oda2- ligand is coordinated to each metal via a single carboxylate oxygen, and this is in a cis position with respect to the bridging carboxylate oxygen. The three remaining oxygen atoms of this oda2" ligand remain uncoordinated.
Overall, in the dianion each Mn(II) atom is at the centre of a distorted N4O2 octahedron. The structure of the dication [Mn2 (oda) (phen)4 (H2O) 2] 2+ is basically similar to that of the dianion in that each of the two symmetry related Mn(II) atoms has a distorted octahedral 4O2 coordination geometry. Each metal is surrounded by two chelating phen groups and one carboxylate oxygen atom from the bridging oda2" ligand. The sixth coordination site is occupied by the oxygen atom of a water molecule which, again, is in a cisoid position with respect to the coordinated carboxylate oxygen atom of the bridging oda2" ligand.
[Mn2 (salH)4 (H20)4] (Complex 3)
The complex comprises two associated and symmetry related pseudo seven-coordinate Mn(II) centres. Each Mn is asymmetrically chelated by two salH" (HOC/5H4CO2") ligands and, perpendicular to the central plane, there are two coordinated water molecules. Association of the two metals occurs via the carboxylate oxygen atoms from a second pair of chelating salH~ ligands, effectively creating two asymmetric bridges between the Mn atoms. The stability of complex (3) in the solid state is further enhanced by intramolecular hydrogen bonding between the hydroxyl groups of the salH" function and one carboxylate oxygen of the same ligand. [ { Mn2 ( sal ) 2 ( salH) ( H20 ) (H30) (py) 4 - 2py } n] (Complex 4 )
The complex comprises three independent Mn(II) atoms {Mnl, Mn2 and Mn3} in a polymeric system of the type
Mnl...Mn3...Mn2...Mn3...Mnl...Mn3...Mn2...Mn3...Mnl..
Mnl lies on an inversion centre and is bonded to a carboxyl oxygen atom and a hydroxyl oxygen atom {both from a sal2" ligand (sal2- = OC6H4CO22") } and also to a pyridine nitrogen. Mn2 lies on another inversion centre and it has an N2O4 octahedral coordination geometry identical to that of Mnl. Mn3 is in a general position, and is bonded to the second carboxylate oxygen atom from the sal2" ligand which is coordinated to Mnl, and also to the second carboxylate oxygen atom from the sal2" ligand which is coordinated to Mn2. The coordination mode of the carboxylate moieties of both of these bridging sal2" ligands is syn-anti bidentate. The oxygen atom of a water molecule and the oxygen atom of a cisoid hydronium ion (H30+: oxygen donor ligand) are also coordinated to Mn3, and the N2O octahedral coordination about the metal is completed by two axial pyridine ligands. Furthermore a salH" ion is hydrogen bonded via its carboxylate oxygens in a syn-syn bidentate bridging mode to the water molecule and to the hydronium ion which are coordinated to Mn3. Additional inter-ligand hydrogen bonding interactions are also present. Two pyridine molecules of solvation are also present in the lattice. The emperical formula of (4) is Mn2 (sal)2 (salH) (H20) (H30) (py)4.2py. [{Mn(salH)2 (bipy) (H20) }n] (Complex 5)
This is a polymeric complex, with each manganese ion at the centre of a distorted octahedron and ligated by both nitrogen atoms of a bipyridine and one carboxylate oxygen from each of four salicylate ligands. The salicylate carboxylate groups each form asymmetric bridges to further manganese atoms, forming spiral chains parallel to the two-fold screw axis.
[Mn(rj1η1-nda) (phen)2l .EtOH.H20 (Complex 8)
The complex comprises a single manganese (II) atom in a distorted six-coordinate geometry. The metal is ligated by two chelating phenanthroline ligands and two carboxylate oxygen atoms (one from each of the two carboxylate functions on the nda2" ligand) . The water molecule is hydrogen bonded to one of the free carbonyl oxygens of the nda2" ligand. The ethanol molecule is hydrogen bonded to this water molecule.
[Mn(bdoa) (H20)3] (Complex 9)
The complex comprises a single seven-coordinate manganese (II) ion. The bdoa2" acts as a chelating quadridentate ligand and is bound to the metal via the two ethereal oxygen atoms and two carboxylate oxygens, one from each end of the diacid. The remaining three coordination sites are occupied by the oxygen atoms of three water molecules. [Mn ( E-uro ) 2 (H20) 4 ] ( Complex 14 )
This complex shows two distinct isomers of [Mn(E-uro) 2 (H2O) 4] . One isomer has the imine nitrogen atom of the imidazole ring lying in a cisoid orientation with respect to the carbon-carbon double bond which bears the pendant carboxylate group, whilst in the other isomer the same nitrogen atom is transoid to the double bond. Both species are centrosymmetric, so that the asymmetric unit comprises two independent half molecules. The geometry at manganese is approximately octahedral, with the metal coordinated by the imine nitrogen atoms from two urocanate anions trans to one another, and also by four water molecules.
Example 16: H2O2 Disproportionation Results for Complexes (1) - (14)
Disproportionation reaction 2H202 ->> 2H20 + 02
All of the complexes (1) - (14) disproportionated H2O2 in the presence of imidazole, and the results of these reactions are set out in Table 1 hereinafter. It should be noted that the base imidazole itself causes only a very slight disproportionation of hydrogen peroxide (see Table 1) and this sluggish reaction is greatly enhanced when the manganese complexes of the invention are included in the reaction mixture. In addition to their ability to disproportionate hydrogen peroxide, the complexes of the invention readily catalytically disproportionated sodium perborate tetrahydrate {NaB03.4H2θ} and sodium percarbonate {Na2CO3.1.5H202}.
EXPERIMENTAL CONDITIONS:
The reaction flask was equipped with a magnetic stirring bar and thermostatted at 25°C. Solid complex (ca 10 mg) and solid imidazole (50 mg) were added to the flask, and then aqueous H2O2 (35% w/w, 10 ml, 114 mmol) was injected using a syringe. The resulting mixture was stirred, and the evolved O2 was measured volumetrically (ml) over a period of time (min) . The results are set out in Table 1 hereinbelow.
TABLE 1
I t o I
* oxygen evolved (ml) at 0.67min
** not determined
*** Use of imidazole only (no Mn(II) complex of the invention present)
Example 17 : H2O2 Disproportionation Results for Complexes (2) and (8) .
Data are given in Table 2 for the disproportion- ation of H2O2 by complexes (2) and (8) in the absence of imidazole.
EXPERIMENTAL CONDITIONS:
The reaction flask was equipped with a magnetic stirring bar and thermostatted at 25°C. Solid complex (ca 10 mg) was added to the flask, and then aqueous H2O2 (35% w/w, 5 ml, 57 mmol) was injected using a syringe. The resulting mixture was stirred, and the evolved O2 was measured volumetrically (ml) over a period of time (min) (see Table 2 annexed) .
As will be observed from Table 2 (hereinafter) , the complexes of the invention also catalyze the disproportionation of H2O2 in the absence of imidazole.
TABLE 2
I t to
I
Example 18
Mn (II) carboxylate complexes of the present invention have been tested in contact with various stains such as tea, coffee and red wine. It is been shown, in these tests, that the complexes of the invention act as effective bleaching catalysts, either in the presence of a nitrogen donor ligand such as imidazole or 1, 10-phenanthroline or in the absence of a nitrogen donor ligand. Accordingly, Mn (II) carboxylate complexes of the present invention are suitable for use in surface cleaners and washing powders .

Claims

CLAIMS :
1. A Mn(II) carboxylate complex or a binuclear or
polynuclear derivative thereof, in which the carboxylate moiety is of the general formula
Y [Om ( CH2 ) qCOOH] p in which m is 0 or 1; q is ≥ 0; p is ≥ 1; Y is selected from the group comprising hydrogen, substituted or unsubstituted lower (C1-20) alkyl, substituted or unsubstituted lower (C2-20)
alkenyl, substituted or unsubstituted lower
(C2-20) alkynyl, substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated carbocyclic ring system, substituted or
unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon or substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated
heterocyclic ring system and, when p is 2, Y additionally is selected from the group comprising substituted or unsubstituted lower (C1-20)
alkylene, substituted or unsubstituted lower
(C2-20) alkenylene or substituted or unsubstituted lower (C2-20) alkynylene; with the proviso that, when m is 0 and q is 0 or 1 and p is 1, Y is not hydrogen.
2. A Mn(II) carboxylate complex according to Claim 1, in which Y is substituted by halogen, hydroxyl, lower (C1-20) alkoxy, nitro, a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated carbocyclic ring system, a
substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon or a substituted or unsubstituted mono-, bi- or polycyclic
saturated or unsaturated heterocyclic ring system.
3. A Mn(II) carboxylate complex according to Claim 1 or 2, in which Y is a carbocyclic ring system selected from the group comprising lower (C3-20) cycloalkyl or a mono-, bi- or polyunsaturated derivative thereof, a fused bi- or polycyclic ring system, a bridged bi- or polycyclic ring system, optionally selected from bi- and polycyclic terpenes, and a bi- or polyspiro ring system.
4. A Mn(II) carboxylate complex according to Claim 3, in which Y is norbornene.
5. A Mn(II) carboxylate complex according to Claim 1 or 2 in which Y is a substituted or unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon, preferably C6-12 aryl, optionally selected from phenyl, benzyl, naphthalenyl and anthracenyl.
6. A Mn(II) carboxylate complex according to Claim 5, in which Y is substituted by halogen, hydroxyl, lower (C1-20) alkoxy or nitro.
7. A Mn(II) carboxylate complex according to Claim 6, in which Y is naphthalenyl or 2-hydroxy-1-phenyl.
8. A Mn(II) carboxylate complex according to Claim 1 or 2, in which Y is (C1-20) lower alkylene, optionally selected from dimethylene,
trimethylene, tetramethylene, pentamethylene and hexamethylene; p is 2; and m and q are each 0.
9. A Mn(II) carboxylate complex according to Claim 1 or 2, in which Y is lower (C2-10) alkenyl
substituted by halogen, hydroxyl, lower (C1-20) alkoxy, nitro, a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated carbocyclic ring system, a substituted or
unsubstituted mono-, bi- or polycyclic aromatic hydrocarbon or a substituted or unsubstituted mono-, bi- or polycyclic saturated or unsaturated heterocyclic ring system.
10. A Mn(II) carboxylate complex according to Claim 9, in which Y is a lower (C2-10) alkenyl, optionally acrylyl, substituted by a heterocyclic ring system, preferably imidazol-4-yl.
11. A Mn(II) carboxylate complex according to any one of the preceding claims, in which the complex additionally comprises at least one oxygen donor ligand optionally selected from water, hydronium ions and lower (C1-20) alkanols, preferably ethanol.
12. A Mn(II) carboxylate complex according to any one of the preceding claims, the complex additionally comprising at least one nitrogen donor ligand selected from substituted or unsubstituted
saturated or unsaturated ring nitrogen-containing mono-, bi-, or polycyclic ring systems, ammonia, substituted or unsubstituted primary, secondary or tertiary amines or bi- or polycyclic fused ring systems.
13. A Mn(II) carboxylate complex according to Claim 12, in which the nitrogen donor ligand is selected from the group comprising substituted or
unsubstituted pyridine, 1,10-phenanthroline and 2,2'-bipyridine.
14. A Mn(II) carboxylate complex according to any one of preceding claims, the complex being selected from the list comprising:
Mn(oda).H2O;
[Mn2(oda)(phen)4(H2O)2] [Mn2(oda)3(phen)4].4H2O;
[Mn2(salH)4(H2O)4];
[{Mn2(sal)2(salH)(H2O)(H3O)(py)4.2py}n];
[{Mn(salH)2(bipy)(H2O)}n];
[Mn(salH)2(phen)];
[Mn(nda)(H2O)];
[Mn(η1η1-nda)(phen)2].EtOH.H2O;
[Mn(bdoa)(H2O)3];
[Mn(bdoa)(phen)2(H2O)];
[Mn(bnda)(H2O)3];
[Mn(bnda) (phen)2(H2O)2];
[Mn(bda)(H2O)2]; and
[Mn(E-uro)2(H2O)4]
in which n is ≥ 1.
15. A process for the preparation of a Mn(II)
carboxylate complex according to any one of Claims 1-11, which process comprises reacting a Mn(II) salt of the formula
Mn(II)L in which L is a leaving group which may optionally be selected from acetate and halogen, preferably chloride, with an appropriate carboxylic acid, or a salt thereof, in a suitable reaction medium, preferably selected from water and an
ethanol:water mixture, more preferably a 4:1 (v:v) ethanol:water mixture, to obtain the Mn(II) carboxylate complex.
16. A process for the preparation of a Mn(II)
carboxylate complex according to Claim 12 or 13, which process comprises:
(i) (a) reacting a Mn(II) salt of the formula
Mn(II)L
in which L is a leaving group which may optionally be selected from acetate and halogen, preferably chloride, with an appropriate carboxylic acid, or a salt thereof, in a suitable reaction medium, preferably selected from water and an
ethanol:water mixture, more preferably a
4 :1 (v:v) ethanol:water mixture, to obtain the
Mn(II) carboxylate complex according to any one of Claims 1-11; and
(i) (b) reacting the Mn(II) carboxylate complex with an appropriate nitrogen donor ligand to obtain the Mn(II) carboxylate complex according to Claim 12 or 13; or (ii) reacting a Mn(II) salt of the formula Mn(II)L
in which L is a leaving group which may optionally be selected from acetate and halogen, preferably chloride, with an appropriate carboxylic acid, or a salt thereof, in a suitable reaction medium, preferably selected from water and an
ethanol:water mixture, more preferably a
4 : 1 (v:v) ethanol: water mixture, the reaction medium also containing an appropriate nitrogen donor ligand, to obtain the Mn(II) carboxylate complex according to Claim 12 or 13.
17. A catalyst for accelerating disproportionation of hydrogen peroxide, hydrogen peroxide-liberating percompounds and hydrogen peroxide-generating percompounds, the catalyst comprising a Mn(II) carboxylate complex according to any one of Claims 1-14.
18. Use of a Mn(II) carboxylate complex according to any one of Claims 1-14 as a disproportionation catalyst.
EP95938006A 1994-11-14 1995-11-14 Novel mn(ii) carboxylate complexes, processes for their preparation and their use as disproportionation catalysts Withdrawn EP0804444A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE940892 1994-11-14
IE940892 1994-11-14
PCT/IE1995/000059 WO1996015136A1 (en) 1994-11-14 1995-11-14 Novel mn(ii) carboxylate complexes, processes for their preparation and their use as disproportionation catalysts

Publications (1)

Publication Number Publication Date
EP0804444A1 true EP0804444A1 (en) 1997-11-05

Family

ID=11040570

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95938006A Withdrawn EP0804444A1 (en) 1994-11-14 1995-11-14 Novel mn(ii) carboxylate complexes, processes for their preparation and their use as disproportionation catalysts

Country Status (3)

Country Link
EP (1) EP0804444A1 (en)
AU (1) AU3880395A (en)
WO (1) WO1996015136A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19714122A1 (en) 1997-04-05 1998-10-08 Clariant Gmbh Bleach-active metal complexes
DE19719397A1 (en) * 1997-05-07 1998-11-12 Clariant Gmbh Bleach-active metal complexes
DE19728021A1 (en) * 1997-07-01 1999-01-07 Clariant Gmbh Metal complexes as bleach activators
ES2746314T3 (en) * 2013-07-24 2020-03-05 Arkema Inc Manganese carboxylates for peroxygen activation
CN104447819B (en) * 2014-11-12 2016-10-05 东北师范大学 Chiral zinc nitrogen complexes of double naphthyl oxalic acid and preparation method thereof
CN106905377B (en) * 2017-02-27 2019-02-19 衡阳师范学院 A kind of cyclopentadienyl double-core chair shape cobalt nitrogen complex and its preparation method and application
RU2737435C1 (en) * 2020-04-30 2020-11-30 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук Mixed metal complexes based on 5-(4-methylphenyl)-2,2'-bipyridine and (tetrafluor) salicylic acids, having antibacterial and fungistatic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025101A (en) * 1990-06-21 1991-06-18 Exxon Research & Engineering Company Novel tetranuclear manganese complexes
US5256779A (en) * 1992-06-18 1993-10-26 Lever Brothers Company, Division Of Conopco, Inc. Synthesis of manganese oxidation catalyst
US5280117A (en) * 1992-09-09 1994-01-18 Lever Brothers Company, A Division Of Conopco, Inc. Process for the preparation of manganese bleach catalyst

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9615136A1 *

Also Published As

Publication number Publication date
AU3880395A (en) 1996-06-06
WO1996015136A1 (en) 1996-05-23

Similar Documents

Publication Publication Date Title
Samanta et al. Recent advances on the chemistry of transition metal complexes of 2-(arylazo) pyridines and its arylamino derivatives
Gramage-Doria et al. Metallated cavitands (calixarenes, resorcinarenes, cyclodextrins) with internal coordination sites
Brudvig et al. Bioinorganic chemistry of manganese related to photosynthetic oxygen evolution
Borovik Bioinspired hydrogen bond motifs in ligand design: the role of noncovalent interactions in metal ion mediated activation of dioxygen
Hikichi et al. Synthesis and characterization of the benzoylformato ferrous complexes with the hindered tris (pyrazolyl) borate ligand as a structural model for mononuclear non-heme iron enzymes
Jenter et al. Aminotroponiminate zinc complexes as catalysts for the intramolecular hydroamination
JPH11500052A (en) Synthesis of manganese oxidation catalyst
Taktak et al. Synthesis and catalytic properties in olefin epoxidation of novel iron (II) complexes with pyridine-containing macrocycles bearing an aminopropyl pendant arm
Coggins et al. Characterization and dioxygen reactivity of a new series of coordinatively unsaturated thiolate-ligated manganese (II) complexes
Yan Poon et al. How metal ion lewis acidity and steric properties influence the barrier to dioxygen binding, peroxo O–O bond cleavage, and reactivity
Hemmert et al. Preparation and Crystal Structures of Manganese, Iron, and Cobalt Complexes of the Bis [di (2‐pyridyl) methyl] amine (bdpma) Ligand and Its Oxidative Degradation Product 1, 3, 3‐Tris (2‐pyridyl)‐3H‐imidazo [1, 5‐a] pyridin‐4‐ium (tpip); Origin of the bdpma Fragility
EP0804444A1 (en) Novel mn(ii) carboxylate complexes, processes for their preparation and their use as disproportionation catalysts
MXPA04012135A (en) Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition.
Aguilar-Calderon et al. Redox-Controlled and Reversible N–N Bond Forming and Splitting with an IronIV Terminal Imido Ligand
Monkcom et al. Bioinspired Non-Heme Iron Complexes: The Evolution of Facial N, N, O Ligand Design
Friese et al. Iron (II) complexes of sterically bulky α-ketocarboxylates. Structural models for α-ketoacid-dependent nonheme iron halogenases
Brudenell et al. Solution and solid state structures of binuclear zinc (II) complexes of bis (pentadentate) ligands derived from bis (1, 4, 7-triazacyclononane) macrocycles
Gao Synthesis, characterisation and transition metal ion complexation studies of “pocket-like” imine and amide derivatives
Godbole et al. Highly efficient disproportionation of dihydrogen peroxide: Synthesis, structure, and catalase activity of manganese complexes of the salicylimidate ligand
Marks et al. NO Coupling by Nonclassical Dinuclear Dinitrosyliron Complexes to Form N2O Dictated by Hemilability
Neisen Modeling the Active Sites of Copper Monooxygenase Enzymes
Pettinari et al. An “Unexpected Journey” in Coordination Chemistry, from Italy to Portugal and Comeback
Johnson Synthesis and Applications of Amide-Based Pd (II) NNN-pincer Complexes
Katsoulakou et al. Synthesis, X‐Ray Structure, and Characterization of Catena‐bis (benzoate) bis {N, N‐bis (2‐hydroxyethyl) glycinate} cadmium (II)
Rain Heterometallic Iron and Iridium Nitrido Complexes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970616

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19980701

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000317